> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-010.md). # BRE 010 ## DNA Repair, MSH2, and Colorectal Cancer **Clinical Cancer Name:** Colorectal Carcinoma **Common Cancer Name:** Colon and Rectal Cancer ## Source Zhao, Y., et al. (2026). *MSH2 Gene Mutations in Colorectal Cancer: Molecular Mechanisms, Prognostic Significance, and Therapeutic Implications.* *Critical Reviews in Oncology/Hematology.* Article 105043. ## BRS Score **BRS:** 6.8 / 10\ **STEMD:** S7 / T8 / E7 / M9 / D3\ **External Evidence Level:** Moderate for colorectal cancer mechanism evidence; Very Low for direct bioelectric or frequency-response evidence ## Score Interpretation BRE-010 receives a moderate BRS because it is highly relevant to cancer biology and DNA repair mechanisms, but it does not provide direct evidence for frequency response, electric-field exposure, Rife frequencies, electromagnetic treatment, or bioelectric intervention. This entry is included because it helps BREXAtlas understand a mechanism that may connect to future bioelectric research: DNA repair failure. ## Entry Summary BRE-010 asks a different kind of question: Could DNA repair pathways become important targets or comparison points for future bioelectric oncology? This paper focuses on MSH2 gene mutations in colorectal cancer. MSH2 is part of the mismatch repair system, which helps cells correct DNA copying mistakes. When MSH2 is mutated or not working properly, errors can accumulate. In colorectal cancer, this can contribute to microsatellite instability, higher mutation burden, altered immune response, and changes in treatment sensitivity. BREXAtlas identifies BRE-010 as supportive biology evidence. It does not prove that electric fields affect MSH2. It does not test frequencies. It does not report a bioelectric treatment. Instead, it maps a cancer-relevant mechanism that future bioelectric studies may need to investigate. ## Question This BRE Helps Answer Why does DNA repair matter in cancer? ### What BREXAtlas found DNA repair matters because cancer cells survive partly by managing genetic damage. MSH2 normally helps correct mistakes during DNA replication. When MSH2 is mutated, the cell may lose repair accuracy. That can lead to: * mismatch repair dysfunction * microsatellite instability * increased mutation burden * tumor progression * altered immune visibility In simple language: MSH2 helps proofread DNA. When that proofreading system fails, cancer can become more genetically unstable. ## Does this study provide frequency evidence? ### What BREXAtlas found No. BRE-010 does not report: * frequency exposure * electric-field treatment * electromagnetic stimulation * resonance therapy * Rife frequency validation * waveform data * field strength * exposure duration This is important because BREXAtlas must not treat every cancer mechanism paper as frequency evidence. BRE-010 belongs in the mechanism index, not the frequency index. ## Why include this paper in BREXAtlas? Because DNA repair has already appeared in earlier TTFields research. BRE-003 showed that TTFields may delay DNA damage repair after radiation in glioma cells. BRE-010 does not prove the same effect in colorectal cancer. But it helps identify one of the biological pathways that may matter if future studies test bioelectric effects on DNA repair. ## Study Classification | Study Type | Classification | | ----------------------------------------- | ------------------------------------ | | Study Type | Comprehensive narrative review | | Primary Classification | Mechanistic biology review | | Secondary Classification | DNA repair / molecular oncology | | Tissue Type | Colorectal | | Cancer Type | Colon carcinoma and rectal carcinoma | | Frequency Evidence | None | | Direct Bioelectric Exposure | None | | Direct Electromagnetic Treatment Evidence | None | | Suitable for Frequency Index | No | | Suitable for Mechanism Index | Yes | | Suitable for Pattern Tracker | Yes | ## Biological Context ### Colorectal Cancer Subtypes Discussed * Colon carcinoma * Rectal carcinoma * MSI-H colorectal cancer * Mismatch repair-deficient tumors * Lynch syndrome-associated cancers ### Cell Line Information No primary cancer cell lines are identified as the focus of this entry. The paper draws from: * MSH2-mutated colorectal cancer cohorts * dMMR populations * MSI-H populations * human-derived clinical datasets * whole genome sequencing studies * molecular profiling studies ## Mechanisms ### MEC-031: Mismatch Repair Dysfunction MSH2 plays a central role in DNA mismatch repair. When MSH2 is altered, DNA replication errors may persist. ### MEC-032: Microsatellite Instability Mismatch repair dysfunction can lead to microsatellite instability, also known as MSI. MSI-H tumors often show higher mutation burden. ### MEC-033: Mutation Burden Increase When repair systems fail, mutations may accumulate. This can influence tumor behavior and treatment response. ### MEC-034: Neoantigen Generation Higher mutation burden may create more abnormal proteins that the immune system can recognize. These abnormal proteins are called neoantigens. ### MEC-035: Immune Microenvironment Alteration MSH2-mutated tumors may show changes in immune infiltration, checkpoint expression, and immune-cell composition. ### MEC-036: Immunotherapy Response Modification MSH2 mutation status may influence response to immunotherapy, especially in mismatch repair-deficient or MSI-H colorectal cancers. ## Relationship Map MSH2 mutation\ ↓\ Mismatch repair deficiency\ ↓\ Microsatellite instability\ ↓\ Mutation accumulation\ ↓\ Neoantigen generation\ ↓\ Immune activation\ ↓\ Altered treatment response ## What BREXAtlas Found BRE-010 contributes to BREXAtlas in four ways: 1. It strengthens the DNA repair mechanism branch. 2. It provides colorectal cancer pathway context. 3. It connects mutation burden to immune response. 4. It identifies future bioelectric research questions involving DNA repair. Its strongest value is not direct treatment evidence. Its strongest value is pathway organization. ## Public Source Validation Public oncology literature recognizes MSH2 as part of the mismatch repair system and recognizes mismatch repair deficiency and MSI-H status as clinically important in colorectal cancer. BREXAtlas uses BRE-010 consistently with that public understanding. The entry is not interpreted as evidence that electric fields affect MSH2. Instead, it is treated as a molecular oncology foundation for future hypothesis generation. ## Connections to Other BRE Entries ### Connected to BRE-003 BRE-003 showed that TTFields delayed DNA damage repair following radiation treatment in glioma cells. BRE-010 provides broader cancer-biology context for why DNA repair pathways matter. **Connection:** DNA repair disruption. Read BRE-003 for: direct TTFields plus radiation evidence. ### Connected to BRE-005 BRE-005 showed immune-system involvement after TTFields exposure. BRE-010 connects DNA repair deficiency to increased mutation burden, neoantigen generation, and altered immune response. **Connection:** cancer-cell damage and immune visibility. Read BRE-005 for: immunogenic cell death and anti-PD-1 response. ### Connected to BRE-009 BRE-009 warned against treating unsupported frequency claims as valid evidence. BRE-010 reinforces that discipline. Although this paper is scientifically valuable, it does not provide direct frequency evidence. **Connection:** evidence classification and boundary-setting. ### Connected to Future Colorectal Cancer Entries BRE-010 becomes a foundational colorectal cancer mechanism entry. Future colorectal entries should compare whether bioelectric or electromagnetic interventions affect: * mismatch repair * MSI-H biology * immune infiltration * treatment response * DNA repair markers ## Research Gaps Identified ### RG-046: Bioelectric-MSH2 Gap Unknown whether membrane-voltage changes regulate MSH2 expression. ### RG-047: Mismatch Repair Interaction Gap Unknown whether bioelectric signaling interacts with mismatch repair pathways. ### RG-048: Frequency-Response Gap No identified frequency-response experiments involving MSH2. ### RG-049: Electromagnetic DNA Repair Gap Unknown whether electromagnetic stimulation modifies DNA repair activity. ### RG-050: Colorectal Bioelectric Translation Gap Unknown whether colorectal cancer bioelectric properties interact with MSI-H or mismatch repair-deficient biology. ## Why This Entry Matters For researchers, BRE-010 identifies DNA repair as a mechanism that may need to be included in future bioelectric oncology models. For patients and families, the message is simple: Some colorectal cancers behave differently because their DNA repair systems are damaged. That damage can influence mutation levels, immune response, and treatment options. BRE-010 does not claim electric fields treat colorectal cancer. It shows why DNA repair must be considered when building a serious cancer-response encyclopedia. ## Entry Conclusion BRE-010 is a mechanism foundation entry. It does not belong in the frequency-response index. It does belong in the DNA repair, immune-response, colorectal cancer, and future hypothesis indexes. The central question emerging from BRE-010 is: Can future bioelectric studies determine whether electrical signaling influences DNA repair pathways in colorectal cancer? For now, the answer is unknown. That is exactly why this entry matters. --- # Agent Instructions This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com. ## Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter: ``` GET https://www.brexatlas.org/bre-001/bre-010.md?ask=&goal= ``` `ask` is the immediate question: it should be specific, self-contained, and written in natural language. `goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.